Clinical Trial Update: Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes [Phase 1]

View source ↗

Summary

The inpatient trial evaluating the MD-Logic Artificial Pancreas System for Type 1 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• MD-Logic Artificial Pancreas System

Snippet

Sponsor: Rabin Medical Center | Conditions: Diabetes Type 1 | Phase 1 | Status: WITHDRAWN